Over the last decade, the notion that the genome folds into physically insulated domains has been applied to several aspects of biology and disease. Topologically associating domains (TADs) are self-interacting chromosome segments ranging from tens of kilobases to a megabase (Dixon et al., 2012; Nora et al., 2012) . They are thought to provide genomic neighborhoods within which genes can interact physically and functionally with regulatory sequences while being shielded from the influence of the genomic elements lying in adjacent domains. As the functional ramifications of this organization are being scrutinized, recent reports have started to establish links with gene misregulation in disease. A notable example is the genomic rearrangements that cause limb patterning defects, which disrupt TAD boundaries and trigger miscommunication between developmental enhancers and genes involved in morphogenesis (Lupiá ñ ez et al., 2015) . In the same vein, disrupting TAD boundaries can ectopically activate neighboring proto-oncogenes and is frequently observed in tumor genomes (Hnisz et al., 2016) .
In this issue of Cell, Sun et al. (2018) now provide compelling evidence that specific TAD boundaries provide a substrate for DNA-repeat expansion as it relates to several diseases, such as fragile X syndrome. These results open new avenues to investigate the causal relationship between genomic instability, chromatin 3D organization, and disease-causing gene misregulation.
Over 1% of the human genome is made up of short tandem nucleotide repeats, also called microsatellites. For the most part, they stay put and do not cause trouble. For around 30 of these regions, however, instability results in their uncontrolled tandem expansion, leading to severe diseases such as Huntington's disease, fragile X syndrome, amyotrophic lateral sclerosis, and Friedrich's ataxia. Most of these are neural or neuromuscular diseases. In trying to understand what makes this subset of repeats especially so unstable, Sun et al. sought to examine the chromatin folding patterns that might characterize disease-associated short tandem repeats (daSTRs). Mining human Hi-C datasets using newly developed computational tools, the authors make the initial observation that many of these tandem repeats localize to TADs or boundaries that occur within TADs (sub-TAD boundaries). Based on embryonic stem cell Hi-C data, 21 of 27 reported repeat expansions localize to TAD or subTAD boundaries and, narrowing to neurological disease, 21 of 23 reported loci similarly localize to these structural landmarks. Importantly, these chromatin structural features are conserved across several cell types, including sperm. These associations are clearly statistically significant compared to other types of repeats in the genome, which are stable, and beg the question of whether this is coincidence or if a disease mechanism lurks at TAD boundaries.
What makes the daSTR-associated boundaries special? Again by association, the authors determine that a high CpG island content is characteristic of tandem repeats associated with disease linked to TAD boundaries. This ties in with another level of epigenomic regulation: aberrant DNA methylation of CpG islands, which occurs concomitantly with gene silencing at pathological CGG expansions of some of these repeats, such as around the FMR1 locus in fragile X syndrome. This has been proposed to be a primary mechanism of FMR1 silencing (Liu et al., 2018) . While cause and consequence remain to be disentangled, this association opens the door for investigating the likely molecular mechanism (Figure 1 ). The authors suggest that differential DNA methylation caused by repeat expansion at these sites may alter binding of factors involved in TAD formation, such as CTCF, thereby reconfiguring chromatin folding for these loci. As we discuss below, this is one of many possibilities that the current work suggests.
The authors follow on these correlations by examining chromatin structure in tissues from patients with fragile X syndrome. They find that chromatin folding around the FMR1 locus is altered in B cells from patients, with FMR1 losing contacts with its telomeric domain and gaining access to its centromeric domain. Importantly, the authors find a similar rearrangement of TAD structure in brain tissue. While limited to fragile X syndrome, these results clearly show that expansion of daSTRs are associated with local changes in chromatin folding. The authors further show that CTCF occupancy is diminished at nearby sites, providing a molecular explanation as to how expansion of the repeat can locally interfere with TAD insulation around the daSTR locus.
Is there a functional consequence of the altered TAD boundary? This is a difficult question to address without a way to experimentally uncouple expansion of the daSTR, FMR1 silencing, and TAD folding. FMR1 expression is greatly reduced in cells from fragile X syndrome patients, leading the authors to propose that, upon dissolution of the TAD boundary, the FMR1 gene loses contact with active telomeric enhancers and is packaged with inactive centromeric sequences, which might contribute to its silencing. It remains to be investigated, however, whether those telomeric enhancers actually play a role for FMR1 activity in healthy people. Future experiments manipulating independent repeat numbers, FMR1 expression, and CTCF binding will help deciphering the underlying molecular pathway.
The major questions that these findings open up are as follows: is the folding pattern of chromatin an inherent modulator of repeat instability? What is the causal link between chromatin folding, DNA methylation, and gene silencing at expanded daSTR loci, and is it possible that they each reinforce each other? If boundaries promote instability, why do only a small fraction of TAD boundaries harbor unstable elements? The authors of the paper raise a number of interesting possibilities. One is that an event that disrupts a stable boundary leads to STR expansion and subsequent methylation and silencing. This would require a genetic trigger, such as a mutation in the CTCF binding site, to occur in the rare individuals with STR expansion-related diseases. Another consideration is that STRs at TAD boundaries may be inherently unstable, perhaps due to their location at junctions of physical domains, and that mechanisms that normally suppress their excessive expansion are disrupted in disease. How these potential mechanisms would then lead to gene silencing is not clear. This may be independent of the altered boundary formation and primarily linked to increased DNA methylation. The DNA methylation could of course be a consequence of a cascade of repeat expansion and chromatin structure (or vice versa). Alternatively, altered domain structure could be the primary determinant of silencing, with DNA methylation as an end point. The fact that TAD boundaries are hotspots for DNA double-strand breaks (Canela et al., 2017 ) may predispose neighboring STRs for expansion, and expansion may in turn modify chromatin folding-for example, by interfering with CTCF binding and transcription by the means of abnormal DNA methylation. All of these questions await experimental exploration and will likely depend on the genomic organization of each locus.
Discoveries on the 3D architecture of the genome have yielded fascinating insights into gene regulation, biophysics of natural polymers, and nuclear organization, among others. Little has been gleaned that relates this overall process to disease. The findings by Sun et al. provide a surprising and highly intriguing set of observations that are likely to lead to important mechanistic insights into the cause and effect of STR-expansionrelated diseases and into the importance and regulation of chromatin structure in general.
